SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-23-040483
Filing Date
2023-11-13
Accepted
2023-11-13 16:06:00
Documents
52
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 789071
2 ex31-1.htm EX-31.1 16360
3 ex31-2.htm EX-31.2 16445
4 ex32-1.htm EX-32.1 8400
  Complete submission text file 0001493152-23-040483.txt   3837207

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE brtx-20230930.xsd EX-101.SCH 24308
6 XBRL CALCULATION FILE brtx-20230930_cal.xml EX-101.CAL 40778
7 XBRL DEFINITION FILE brtx-20230930_def.xml EX-101.DEF 125224
8 XBRL LABEL FILE brtx-20230930_lab.xml EX-101.LAB 241643
9 XBRL PRESENTATION FILE brtx-20230930_pre.xml EX-101.PRE 200024
46 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 532998
Mailing Address 40 MARCUS DRIVE MELVILLE NY 11747
Business Address 40 MARCUS DRIVE MELVILLE NY 11747 (631) 760-8100
BioRestorative Therapies, Inc. (Filer) CIK: 0001505497 (see all company filings)

IRS No.: 911835664 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37603 | Film No.: 231398620
SIC: 8090 Services-Misc Health & Allied Services, NEC